P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY

• Jing Lu,
• Huifen Zhou,
• Xin Zhou,
• Yonggong Yang,
• Laigen Tong,
• Miao Miao,
• Xiaofei Yang,
• Suning Chen

Affiliations

Jing Lu

1 The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Department of Hematology, Suzhou, China

Huifen Zhou

1 The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Department of Hematology, Suzhou, China

Xin Zhou

2 Wuxi People’s Hospital Affiliated to Nanjing Medical University, Department of Hematology, WuXi, China

Yonggong Yang

3 The Affiliated Drum Tower Hospital of Nanjing University Medical School, Department of Hematology, Nanjing, China

Laigen Tong

4 Yixing People’s Hospital, The Affiliated Hospital of Jiangsu University, Department of Hematology, Yixing, China

Miao Miao

1 The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Department of Hematology, Suzhou, China

Xiaofei Yang

1 The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Department of Hematology, Suzhou, China

Suning Chen

1 The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Department of Hematology, Suzhou, China